Glympse Bio Company

Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis.Glympse Bio - Crunchbase Company Profile & this helpful?

Founded Date: 2015-01-01
Technology: ['BioTech & HealthTech']
Total Funding: 93299987.0
Headquarters: Cambridge, Massachusetts, United States
Last Funding Date: 2021-12-17
Investors Number: 17.0
Last Funding Type: Venture - Series Unknown
Estimated Revenue: $1M to $10M
Industry: Medical BioTech